Paula Ragan

CIK: 0001769914

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CAMP

Camp4 Therapeutics Corp

Director

XFOR

X4 Pharmaceuticals, Inc

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

CAMP
Camp4 Therapeutics Corp
Jun 25, 2025
Award(A)
Stock Option (Right to Buy)
Direct
9K shares-
XFOR
X4 Pharmaceuticals, Inc
Feb 12, 2025
Award(A)
Direct
2.3M shares-
XFOR
X4 Pharmaceuticals, Inc
Jan 24, 2025
Sale(S)
Direct
76.5K shares at avg. $0.45$35K
XFOR
X4 Pharmaceuticals, Inc
Jan 23, 2025
Award(A)
Direct
169.9K shares-
XFOR
X4 Pharmaceuticals, Inc
Nov 15, 2024
Sale(S)
Direct
31.9K shares at avg. $0.39$13K
XFOR
X4 Pharmaceuticals, Inc
Oct 15, 2024
Sale(S)
Direct
31.9K shares at avg. $0.56$18K
XFOR
X4 Pharmaceuticals, Inc
Oct 7, 2024
Sale(S)
Direct
239.4K shares at avg. $0.55$132K
XFOR
X4 Pharmaceuticals, Inc
Oct 4, 2024
Award(A)
Direct
532.1K shares-

		Type	Shares	Price		Ownership
Jun 25, 2025	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	9,000	-	-	Direct
Feb 12, 2025	XFOR X4 Pharmaceuticals, Inc	Award(A)	2,250,000	-	-	Direct
Jan 24, 2025	XFOR X4 Pharmaceuticals, Inc	Sale(S)	76,473	$0.45	$34,719	Direct
Jan 23, 2025	XFOR X4 Pharmaceuticals, Inc	Award(A)	169,940	-	$0	Direct
Nov 15, 2024	XFOR X4 Pharmaceuticals, Inc	Sale(S)	31,897	$0.39	$12,583	Direct
Oct 15, 2024	XFOR X4 Pharmaceuticals, Inc	Sale(S)	31,897	$0.56	$17,926	Direct
Oct 7, 2024	XFOR X4 Pharmaceuticals, Inc	Sale(S)	239,436	$0.55	$131,522	Direct
Oct 4, 2024	XFOR X4 Pharmaceuticals, Inc	Award(A)	532,081	-	$0	Direct

1-8 of 8 transactions

About Ragan Paula

Ragan Paula (SEC CIK 0001769914) files insider reports with the SEC as Director of Camp4 Therapeutics Corp (CAMP) and President and CEO of X4 Pharmaceuticals, Inc (XFOR).

Signal8 holds 7 ownership filings by Ragan Paula (1 Form 3, 6 Form 4), filed between Oct 8, 2024 and Jun 27, 2025. Those filings report 8 transactions, from Oct 4, 2024 to Jun 25, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Ragan Paula's filings is in BOSTON, MA.

Recent filings by Ragan Paula

Jun 25, 2025: Grant or award of CAMP derivative securities (Form 4, code A).
Feb 12, 2025: Grant or award of XFOR shares (Form 4, code A).
Jan 24, 2025: Open-market sale of XFOR shares (Form 4, code S).
Jan 23, 2025: Grant or award of XFOR shares (Form 4, code A).
Nov 15, 2024: Open-market sale of XFOR shares (Form 4, code S).

Other insiders filing for Camp4 Therapeutics Corp (CAMP)

Gold Kelly, Chief Financial Officer
Schwab Andrew J., Director
Tardiff Daniel, Chief Scientific Officer
5AM Partners VI, LLC, 10% Owner
Young Richard A, Director
Maricich Yuri, Chief Medical Officer

How to read Form 4 transaction codes